INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹70 Cr | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹20 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 26.54 | |
| Mar2024 | ₹56 Cr | 16.82 | |
| Mar2023 | ₹48 Cr | 36.64 | |
| Mar2022 | ₹35 Cr | 72.77 | |
| Mar2021 | ₹20 Cr | - | |
Compare Net Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹217.1 Cr | 0.8% | 8.9% | -32.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,668.5 Cr | 2.7% | 0.3% | -16.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,755.5 Cr | -0.1% | 14.1% | -32.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,238.8 Cr | 8.9% | 31% | -6.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,052.8 Cr | 1.9% | 22.3% | -12.9% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹426.1 Cr | 8.2% | 26.6% | -0.8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 0.8% |
8.9% |
-32.3% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses